CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 46 filers reported holding CATALYST BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $43,435 | +37.4% | 90,058 | +0.2% | 0.01% | +75.0% |
Q2 2023 | $31,604 | +69.9% | 89,886 | 0.0% | 0.00% | +100.0% |
Q1 2023 | $18,606 | -61.0% | 89,886 | -0.7% | 0.00% | -71.4% |
Q4 2022 | $47,730 | +6.1% | 90,484 | +0.3% | 0.01% | -22.2% |
Q3 2022 | $45,000 | -72.9% | 90,188 | -3.5% | 0.01% | -78.6% |
Q2 2022 | $166,000 | +137.1% | 93,434 | -11.9% | 0.04% | +82.6% |
Q1 2022 | $70,000 | -30.7% | 106,089 | -4.4% | 0.02% | -57.4% |
Q4 2021 | $101,000 | – | 110,991 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |